Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-pbm
/
Psyence Biomedical Ltd
PBM
4.610
USD
+2.250
+95.36%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
103.28K
Market Cap
Loss
P/E TTM
Psyence Biomedical Ltd
4.610
+2.250
+95.36%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q4
FY2024Q2
Total equity
Cash, cash equivalents and short-term investments
--
733.19K
--
599.09K
- Cash and cash equivalents
--
733.19K
--
599.09K
Receivables
--
41.75K
--
18.71K
-Other receivables
--
41.75K
--
18.71K
Prepaid expenses
--
322.13K
--
15.45K
Other current assets
--
29.61K
--
33.31K
Total current assets
--
1.13M
--
666.56K
Non-current assets
Net Fixed Assets
--
5.49K
--
--
Total non-current assets
--
5.49K
--
--
Total assets
--
1.13M
--
666.56K
Liabilities
Current liabilities
-Other payables
--
2.79M
--
--
Short-term debt and lease liabilities
--
7.66M
--
733.96K
-Short-term debt
--
7.66M
--
733.96K
Other current liabilities
--
2.79M
--
--
Total current liabilities
--
12.10M
--
1.65M
Non-current liabilities
Long-term debt and lease liabilities
--
0.00
--
0.00
Total liabilities
--
12.10M
--
1.65M
Shareholders' equity
Common equity
--
46.13M
--
--
Retained earnings
--
-57.46M
--
--
Total equity
--
-10.97M
--
-978.55K
Currency unit
USD
USD
Audit opinions
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up